The verified answer
As of Oct 2026, DEPLOY verifies Embla Medical hf: 1 model, 2 deployments across 2 regions, 2 active incidents. 1 source back the record.
Overview
Embla Medical hf (formerly Oessur hf) is an Icelandic medical device company specializing in non-invasive prosthetics, neuro orthotics, and bracing solutions. Founded in 1971 by prosthetist Oessur Kristinsson, the company operates globally under brands including Oessur, College Park, and FIOR and GENTZ, with products like the Rheo Knee and POWER KNEE bionic prosthetics. Listed on Nasdaq Copenhagen under ticker EMBLA
Verified record
- Verified deployments
- 2 deployments on file
- Active incidents
- 2 incidents on file
Key facts
Former name
Products
CEO
Founder
Revenue
Employees
Key Products
Notable Acquisitions
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Partnerships
Every company Embla Medical hf has built with, alongside the ones only announced in a press release.
Most-frequent partners
- 1FIOR and GENTZ1× joint
Most recent
- Oessur acquires FIOR and GENTZ2024-01-15with FIOR and GENTZoperating
Embla Medical hf on the deployment map
View the global map2 verified deployments across 2 regions, newest verified Jun 2024. Explore where Embla Medical hf's robots are operating, by place and type.
View the full Embla Medical hf deployment record →
Relationships
Current leadership (1)
- Sveinn Sölvason President & CEOsecondary-verified
Founders (1)
- Ossur Kristinssoncofounderno longer at company
previously at Ossur
Former / Previously (2)
- Ossur Kristinsson Foundersecondary-verified
- Niels Jacobsen Chairman of the Boardsecondary-verified
Safety record
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting Embla Medical hf (2)
- FDA Class 2 recall of Oessur Total Knee 2100 due to faulty back links2011-02-11 · Recall
via Rheo Knee at Germany, Europe
- FDA Class 2 recall of Össur Total Knee Junior prosthetic knee due to balancing unit failure2009-08-10 · Recall
via Rheo Knee at Germany, Europe
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Operator customers (1)
- Embla Medical hf2 deployments
Recent coverage
Embla Medical hf in third-party press
Peer companies
- Google21 models
- Roborock20 models
- ST Telemedia Global Data Centres11 models
- Unitree Robotics10 models
- Teraco Data Environments8 models
- AirTrunk7 models
Financial state
- Employees
- 4,078
- Reporting basis
- private_reported
- Revenue disclosed
- $929000000 (private_reported)
- Lifecycle stage
- mature
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Partnerships
1 total · 1 operating · 1 ended
Every company Embla Medical hf has built with, alongside the ones only announced in a press release.
Most recent
- Oessur acquires FIOR and GENTZ2024-01-15with FIOR and GENTZoperating
Most-frequent partners
- 1FIOR and GENTZ1× joint
All 1 partnerships
open in the atlas →- Oessur acquires FIOR and GENTZwithFIOR and GENTZother2024-01-15concludedoperating
Timeline
Every recorded move in Embla Medical hf’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
PartnershipOessur acquires FIOR and GENTZ
2024-01-15Oessur (now Embla Medical) acquired all shares of privately owned Fior and Gentz, a leading German maker of lower limb neuro orthotic components, to enter the fast-growing neuro orthotics market. Fior and Gentz operates under the Embla Medical umbrella as a product brand.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 27, 2026
Added to the verified registry
- Deployment verifiedVerifiedJun 1, 2024
Rheo Knee at United States (multiple hotel chains)
- Deployment verifiedVerifiedJun 1, 2024
Rheo Knee at Germany, Europe
- Incident recordedFeb 11, 2011
FDA Class 2 recall of Oessur Total Knee 2100 due to faulty back links
- Incident recordedAug 10, 2009
FDA Class 2 recall of Össur Total Knee Junior prosthetic knee due to balancing unit...
Sources (1)
Common questions
What is Embla Medical hf?
What does Embla Medical hf make?
Is Embla Medical hf publicly traded?
Who competes with Embla Medical hf?
Who is the CEO of Embla Medical hf?
How can I invest in Embla Medical hf?
Where is Embla Medical hf headquartered?
Who owns Embla Medical hf?
Where does Embla Medical hf operate robots?
How many robots has Embla Medical hf deployed?
Is Embla Medical hf a top robotics company?
Are there any incidents involving Embla Medical hf?
Is Embla Medical hf safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Embla Medical hf.Peer companies
- Google21 models
- Roborock20 models
- ST Telemedia Global Data Centres11 models
- Unitree Robotics10 models
- Teraco Data Environments8 models
- AirTrunk7 models
In the press
Recent coverage mentioning Embla Medical hf from third-party publications. Automatically surfaced; not part of the verified registry record.
Embla Medical Secures Seven-Year NIB Financing for Healthcare Technology Development
(IN BRIEF) NIB has signed a EUR 50 million, seven-year loan with Embla Medical hf. The financing will support Embla Medical’s research and development activities from 2027 to…
Embla Medical Posts 2Q 2026 Financial Results
Q2 2026 sales reached USD 259 million with 11 percent reported growth and 6 percent organic growth, EBITDA margin of 22 percent
Embla Medical named one of the world's best companies in sustainable growth 2026
Embla Medical recognized as one of the world's best companies in sustainable growth for 2026
Embla Medical Recognized for Leadership in Accessibility and International Reach
Forbes Magazine named Embla Medical to its first-ever global Accessibility 100 list, recognizing the company's innovative prosthetics, neuro orthotics and bracing solutions
Embla Medical - ODT Magazine Company Profile
ODT Magazine profiles Embla Medical (formerly Össur), ranked #9 in orthopedic devices with 55M in 2024 sales, covering its rebrand, FIOR & GENTZ acquisition, and new bionics…
Össur - Wikipedia
Wikipedia article on Össur (now Embla Medical), covering the company's history from 1971 founding, acquisitions, bionics research with Alfred Mann Foundation, and global…
Embla Medical hf.: Target Price Consensus and Analysts Recommendations | EMBLA | IS0000000040 - marketscreener.com
<a…
Oessur establishes new parent organization to be named Embla Medical
Oessur proposes establishing Embla Medical as the new parent organization and listed company, reflecting its evolution into a multi-brand mobility solutions provider
Embla Medical signs agreement to invest in a majority stake
Embla Medical (formerly Össur) announces the establishment of its new parent company structure and FIOR & GENTZ acquisition, broadening its neuro orthotics portfolio.
Oessur acquires FIOR and GENTZ
Oessur signed an agreement to acquire all shares of privately owned Fior and Gentz, a leading maker of lower limb neuro orthotic components, entering the fast-growing neuro…
Machine-readable surfaces
- Markdown mirror: /companies/embla-medical.md
- RSS feed: /companies/embla-medical/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/75a567ec-e23a-47f6-8814-12705a627540
- Revision history: /companies/embla-medical/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Google21 models
- Roborock20 models
- ST Telemedia Global Data Centres11 models
- Unitree Robotics10 models
- Teraco Data Environments8 models
- AirTrunk7 models
Video
Heat Index
Serious52/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Embla Medical hf draws attention at the 66th percentile but verifies reality at the 35th percentile among other robots. Hype Gap +30.6, 78th widest among other robots.
6-month trend
Analysis
Safety profile within acceptable range for category. Limited public funding data for capital position assessment.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Oct 5, 2026